Heart attacks and strokes are among the leading causes of death globally, with millions suffering from cardiovascular diseases (CVD) every year. There are more than seven million people in the UK alone, with about 100,000 patients experiencing heart attacks annually. However, a group of researchers at University College London (UCL) estimate that one 'polypill' taken daily day could eliminate a majority of these cases dramatically lowering death tolls.

The proposed polypill, a combination of a statin and three blood pressure-lowering drugs, has been under study for over two decades. Experts argue that introducing this pill universally for individuals aged 50 and above could be more effective than the current NHS Health Check, which assesses risk factors every five years for those aged between 40 and 74.

Studies have repeatedly proven the effectiveness of the polypill in preventing CVD. A groundbreaking 2019 study in The Lancet found that five years' use of the polypill cut the risk of heart attack and stroke by a third. In addition, previous modelling analyses have estimated that if given universally to people over 55, the polypill might be able to prevent 80% of heart attacks and strokes.

Today, the NHS Health Check follows a risk-based model in which patients are tested for CVD risk factors and treated with drugs accordingly. Yet, as per UCL's study, this system has serious flaws:

Low Uptake: Just 40% of those eligible for the NHS Health Check choose to have it, leaving a considerable number of at-risk patients undiagnosed and untreated.

Ineffective Prediction of Risk: The majority of heart attacks and strokes happen to people at average risk levels, thus making it challenging to identify the need for intervention effectively.

Limited Effectiveness: Even at maximum take-up, the NHS Health Check programme is predicted to have fewer health impacts compared to a polypill initiative applied to the whole population.

Simplicity and Affordability of the Polypill Strategy

One of the big benefits of the polypill is that it is so easy. In contrast to the existing screening-based model, the polypill scheme would not involve complicated medical tests or lengthy risk assessments. Instead, people reaching 50 would just have to fill out a few questions to determine possible side effects before they were prescribed.

Professor Aroon Hingorani of the UCL Institute of Cardiovascular Science, one of the strongest proponents of this scheme, says:

"Finally, the time is now to do much better on prevention. A population approach would prevent a lot more heart attacks and strokes than is done today with a strategy of trying to target a smaller group only."

Aside from the possible health implications, the polypill is also an economic solution. The drugs used are off-patent, thus cheap to produce and distribute. With the vast economic cost of managing CVD-related illnesses, a preventive model could result in substantial cost-saving for the NHS in the future.

The polypill has been proven to be effective by numerous international trials. In 2019, a randomised trial in rural Iran discovered that participants who took the polypill for five years had a 34% reduced risk of having a heart attack or stroke compared to non-participants.

Likewise, modelling research has indicated that even if only 8% of people aged over 50 took up the polypill regimen, it would still be more beneficial to their health than the NHS Health Check programme.

Is This a Case of Over-Medicalisation?

One of the main objections to the polypill strategy is the suggestion that it might result in the unnecessary medicalisation of a significant proportion of the population. But, it is argued, it should be considered as a preventative measure, not as mass medication.

Professor Sir Nicholas Wald of UCL's Institute of Health Informatics explains:

"Instead of being a 'medicalisation' of a significant proportion of the population, a polypill programme is a prevention measure to prevent an individual from becoming a patient."

He compares it with public health measures like water fluoridation or compulsory seatbelts—interventions that have been shown to have a significant impact in reducing public health danger at low individual cost.

With the evidence in favour of the polypill's effectiveness and viability overwhelming, experts are calling on the NHS to act now. It is their belief that substituting the NHS Health Check with a polypill-based prevention program could be the UK government's flagship policy under its pledge to put disease prevention ahead of cure.

As Professor Hingorani points out, "The status quo is not a justifiable option." With CVD still a major cause of death globally, taking a population-wide polypill approach could be a turning point for preventative medicine, potentially saving thousands of lives annually. The question now is whether the NHS will take up this call and establish a policy with the potential to transform the prevention of cardiovascular disease on a national level.

Nipah virus Outbreak In India: After two cases of Nipah virus were confirmed in Kolkata, one of the nurses who has recovered from Nipah virus died of a cardiac arrest. Health and Me previously reported on the male nurse being discharged.

Nipah Virus Outbreak In India: What Happened With The Nurse?

The 25-year-old nurse who recovered from Nipah virus infection died of cardiac arrest on Thursday. As per the official statement given to news agency PTI, "She died of cardiac arrest this afternoon. Though she had recovered from Nipah infection, she was suffering from multiple complications."

The reports show that she also developed a lung infection and contracted a hospital-acquired infection during treatment. The official said, "She was trying to regain consciousness, move her limbs, and speak before her condition suddenly deteriorated. She died at around 4.20pm."

The nurse fell ill in early January after returning home on December 31 for the New Year holidays and was initially admitted to Burdwan Medical College and Hospital before being shifted to the private hospital in Barasat.

Nipah Virus Outbreak In India: What Is Nipah Virus?

As per the World Health Organization (WHO), Nipah virus infection is a zoonotic illness that is transmitted to people from animals, and can also be transmitted through contaminated food or directly from person to person.

In infected people, it causes a range of illnesses from asymptomatic (subclinical) infection to acute respiratory illness and fatal encephalitis. The virus can also cause severe disease in animals such as pigs, resulting in significant economic losses for farmers.

Although Nipah virus has caused only a few known outbreaks in Asia, it infects a wide range of animals and causes severe disease and death in people.

Nipah Virus Outbreak In India: What Are The Common Symptoms?

• Fever
• Headache
• Breathing difficulties
• Cough and sore throat
• Diarrhea
• Vomiting
• Muscle pain and severe weakness

Nipah Virus Outbreak In India: What Are Experts Saying?

Dr Krutika Kupalli, a Texas-based expert who formerly also worked with the World Health Organization (WHO), told The Daily Mail that the possibility of Nipah virus outbreak is 'absolutely' something the Centers for Disease Control and Prevention (CDC) should be 'closely monitoring'.

Read: Experts Reveal Risks Of Nipah Virus Outbreak In The US, CDC On Alert

“Nipah virus is a high-consequence pathogen, and even small, apparently contained outbreaks warrant careful surveillance, information sharing, and preparedness. Outbreaks like this also underscore the importance of strong relationships with global partners, particularly the WHO, [which] plays a central role in coordinating outbreak response and sharing timely, on-the-ground information," she said.

A CDC spokesperson told The Daily Mail that the agency is in 'close contact' with authorities in India. "CDC is monitoring the situation and stands ready to assist as needed."

CDC Travel Advisory: The US has warned travelers to be careful if they plan to visit the Seychelles islands anytime soon. The island is located in northeast of Madagascar and is known for its secluded beaches. As per the Centers for Disease Control and Prevention (CDC), a 'Level 2' advisory for the island has been issued and travelers have been asked to 'practice enhanced precautions' if they do plan to visit.

CDC Travel Advisory: Why Did US Issue Health Warning?

The warning has been issue in response to an outbreak of chikungunya, which is a viral disease that could spread to humans by mosquitoes.

A Level 2 travel advisory has been issued, which means the travelers are expected to practice enhanced precautions as compared to a Level 1 advisory that only asks travelers to practice usual precautions.

In more serious cases, Level 3 advisory is issued that asks travelers to reconsider non-essential travel, whereas a Level 4 advisory asks travelers to avoid all travel.

Read: Chikungunya Spreads Across Tamil Nadu: All You Need To Know

CDC Travel Advisory: What Is Level 2 Health Warning?

As CDC issues travel advisory, here is what travelers are expected to do:

• Travelers are expected to protect themselves by preventing mosquito bites, which includes using insect repellent, wearing long-sleeved shirts and pants, and staying in places where air conditioning or that have screens on the windows and doors
• The CDC also tells travelers to get vaccinated for those who are visiting the area affected by a chikungunya outbreak
• If a traveler is pregnant, they are asked to reconsider travel to affected area, especially if they are closed to delivering their baby. Mothers infected around the time of delivery can pass the virus to their baby before or during delivery. Newborns infected in this way or by a mosquito bite are at risk for severe illness, including poor long-term outcomes
• If someone has a fever, joint pain, headache, muscle pain, joint swelling, or rash during or after the travel, they must seek medical care

CDC Travel Advisory: Which Other Places Got The Chikungunya Level 2 Notice

From September 26, 2025 to February 11, 2026, the CDC issued travel advisory against five places for Chikungunya, which includes:

• Bolivia: There is an outbreak of chikungunya in Santa Cruz and Cochabamba Departments
• Seychelles: Notice details mentioned above
• Suriname
• Sri Lanka
• Cuba

CDC Travel Advisory: What Is Chikungunya?

This is a disease that is transmitted from mosquitoes to humans and affects many people in the world. Found in densely populated countries and continents, like Africa, Asia and the tropics of the Americas, this has severe symptoms. This viral disease is caused by the Chikungunya virus of the Togaviridae.

First identified in the United Republic of Tanzania in 1952 and subsequently in other countries like Africa and Asia. Since 2004 the outbreak of CHIKV virus has become more widespread and caused partly due to the viral adaptations allowing the virus to be spread more easily by Aedes albopictus mosquitoes. The transmission has been noted to persist in countries where there is a large population, but interestingly, the transmission has been interrupted on islands where a high proportion of the population is infected and then immune.

CDC Travel Advisory: Symptoms of Chikungunya

The onset of the disease is usually in 4-8 days and after a bite of an infected mosquitoes, it is characterized by an abrupt onset of fever and then joint pain. This joint pain is severed and lasts for a few days but may prolong for months maybe even years. Other signs are joint swelling, muscle pains, headache, nausea, fatigue and rash.

In a now viral video from Trustified, an independent testing platform, food testers claim that Amul Taaza and Gold milk pouches contain coliform bacteria levels 98 times higher than FSSAI’s prescribed limits.

Additionally, Mother Dairy and Country Delight milk pouches showed total plate count levels far above safe thresholds. Total plate count (TPC), also known as Aerobic plate count (APC), measures viable microbial contamination, with lower levels indicating better quality.

Last month, the agency also claimed that the Amul Masti Dahi sold in pouches showed high coliform bacteria, yeast and mold, while tetrapack milk and dahi sold in cups passed quality checks.

However, Amul has aggressively dismissed these allegations, citing them to be fear-mongering and noting that all of its products meet safety standards. Instead of manufacturing failure, the company has pointed to possible breaks in the cold chain at the retail or distribution level.

What Is Coliform Bacteria?

According to ScienceDirect.com, coliform bacteria are rod-shaped, gram-negative bacteria that do not form spores. They may or may not be able to move and they can break down lactose to produce acid and gas when grown at 35–37°C.

E. coli is a specific type of coliform bacteria that lives in the intestines of humans and animals and can cause infections in your gut, urinary tract and other parts of your body.

Coliform bacteria typically doesn't cause serious illness but if high amounts of coliform bacteria are found, it suggests that harmful germs from feces, like bacteria, viruses or parasites, may also be present.

Certain strains of coliform bacteria can make you sick with watery diarrhea, vomiting and a fever, according to Cleveland Clinic.

In many Indian milking setups, milk is extracted by hand and there is a high possibility that cows' udders are not being cleaned thoroughly before extracting milk from them, making it easy for bacteria in the cow dung to contaminate milk.

Why Is Milk Pasteurization Necessary?

Developed by Louis Pasteur in the 19th century, pasteurization is a critical food safety process that involves heating liquids, most commonly milk but also juice, eggs and beer, to a specific temperature for a set period to destroy harmful bacteria, viruses, and pathogens including E. coli, Campylobacter, Listeria, and Salmonella.

This process significantly reduces the risk of foodborne illnesses such as typhoid, tuberculosis, and listeriosis without significantly altering the nutritional value or taste of the product.

In most milk processing plants, chilled raw milk is heated by passing it between heated stainless-steel plates until it reaches 161 degrees Fahrenheit. It’s then held at that temperature for at least 15 seconds before it’s quickly cooled back to its original temperature of 39 degrees.

Pasteurization is essential for children, pregnant women and the immunocompromised, as it prevents infections that can cause severe complications, including miscarriage or death.

Unlike sterilization, pasteurization does not destroy all microorganisms, which is why pasteurized milk must be kept refrigerated.

John Lucey, a food science professor at University of Wisconsin-Madison, notes: "Pasteurization is an absolutely critical control point for making dairy products safe. There really isn’t another single aspect that is as important as it is. If there is a pathogen or anything in the milk that we don’t want, pasteurization destroys it. It is our industry’s shield."